Latest updates

News article | December 22, 2023

Explained: Silicone sound abatement foam used in DreamStation 2 and the sleep and respiratory care devices remediated as part of the June 2021 Philips Respironics recall*

Sleep & Respiratory care
Press release | November 29, 2023

Philips statement on recent FDA safety notification related to DreamStation 2

Sleep & Respiratory care
Press release | October 28, 2023

Philips statement on recent media article related to Philips Respironics’ voluntary recall notification/field safety notice

Sleep & Respiratory care
Press release | October 06, 2023

Philips provides update on Respironics recall

Sleep & Respiratory care
Press release | September 27, 2023

Philips response to recent media articles related to Philips Respironics’ voluntary recall notification/field safety notice

Sleep & Respiratory care

Frequently asked questions (last updated October 23, 2023)

Philips Respironics - Update on PE-PUR testing results and conclusions available to date - Full Report

This page is intended to provide the latest information on the Philips
Respironics voluntary recall notification, as well as an overview of
previous updates, for media.

Healthcare providers, patients, and other stakeholders should visit:
www.philips.com/src-update

Previous updates

Media contact

If you are representing media and have a question about Philips, please reach out to our media contact for support.

Steve Klink

Philips Global Press Office

Tel: +31 6 10888824

You are about to visit a Philips global content page

Continue

Mario Fante

Philips Global Press Office

Tel: +1 603 560 9226

You are about to visit a Philips global content page

Continue

Get the latest Philips news in your inbox

Subscribe

Philips Respironics voluntary recall notification: media updates

Latest updates

Explained: Silicone sound abatement foam used in DreamStation 2 and the sleep and respiratory care devices remediated as part of the June 2021 Philips Respironics recall*

Philips statement on recent FDA safety notification related to DreamStation 2

Philips statement on recent media article related to Philips Respironics’ voluntary recall notification/field safety notice

Philips provides update on Respironics recall

Philips response to recent media articles related to Philips Respironics’ voluntary recall notification/field safety notice

Frequently asked questions (last updated October 23, 2023)

Philips Respironics - Update on PE-PUR testing results and conclusions available to date - Full Report

This page is intended to provide the latest information on the Philips
Respironics voluntary recall notification, as well as an overview of
previous updates, for media.

Healthcare providers, patients, and other stakeholders should visit:
www.philips.com/src-update

Previous updates

Philips reaches resolution of US economic loss litigation

Philips Respironics - PE-PUR testing results and conclusions available to date

Philips provides update on completed set of test results for CPAP/BiPAP sleep therapy devices

Philips provides update on completed set of test results for first-generation DreamStation sleep therapy devices

Philips Respironics provides update on filed MDRs in connection with the voluntary recall notification/field safety notice* for specific CPAP, BiPAP and mechanical ventilator devices

Philips Respironics update related to Trilogy 100/200 repairs

Philips provides update on Philips Respironics’ PE-PUR sound abatement foam test and research program

Summary of a systematic literature review of Positive Airway Pressure device use and cancer risk

Philips Respironics provides update on filed MDRs in connection with the voluntary recall notification/field safety notice* for specific CPAP, BiPAP and mechanical ventilator devices

Philips Respironics provides update for the US on ongoing CPAP, BiPAP and Mechanical Ventilator field action

Philips provides update on the test and research program in connection with the CPAP, BiPAP and Mechanical Ventilator recall notification*

Philips provides update on earlier announced voluntary CPAP, BiPAP and Mechanical Ventilator recall notification

Philips starts repair and replacement program of first-generation DreamStation devices in the US in relation to earlier announced recall notification

Philips issues recall notification* to mitigate potential health risks related to the sound abatement foam component in certain sleep and respiratory care devices

Media contact

Steve Klink

Mario Fante

Get the latest Philips news in your inbox

Philips Respironics voluntary recall notification: media updates

Latest updates

Explained: Silicone sound abatement foam used in DreamStation 2 and the sleep and respiratory care devices remediated as part of the June 2021 Philips Respironics recall*

Philips statement on recent FDA safety notification related to DreamStation 2

Philips statement on recent media article related to Philips Respironics’ voluntary recall notification/field safety notice

Philips provides update on Respironics recall

Philips response to recent media articles related to Philips Respironics’ voluntary recall notification/field safety notice

Frequently asked questions (last updated October 23, 2023)

Philips Respironics - Update on PE-PUR testing results and conclusions available to date - Full Report

This page is intended to provide the latest information on the Philips Respironics voluntary recall notification, as well as an overview of previous updates, for media. Healthcare providers, patients, and other stakeholders should visit: www.philips.com/src-update

Previous updates

Philips reaches resolution of US economic loss litigation

Philips Respironics - PE-PUR testing results and conclusions available to date

Philips provides update on completed set of test results for CPAP/BiPAP sleep therapy devices

Philips provides update on completed set of test results for first-generation DreamStation sleep therapy devices

Philips Respironics provides update on filed MDRs in connection with the voluntary recall notification/field safety notice* for specific CPAP, BiPAP and mechanical ventilator devices

Philips Respironics update related to Trilogy 100/200 repairs

Philips provides update on Philips Respironics’ PE-PUR sound abatement foam test and research program

Summary of a systematic literature review of Positive Airway Pressure device use and cancer risk

Philips Respironics provides update on filed MDRs in connection with the voluntary recall notification/field safety notice* for specific CPAP, BiPAP and mechanical ventilator devices

Philips Respironics provides update for the US on ongoing CPAP, BiPAP and Mechanical Ventilator field action

Philips provides update on the test and research program in connection with the CPAP, BiPAP and Mechanical Ventilator recall notification*

Philips provides update on earlier announced voluntary CPAP, BiPAP and Mechanical Ventilator recall notification

Philips starts repair and replacement program of first-generation DreamStation devices in the US in relation to earlier announced recall notification

Philips issues recall notification* to mitigate potential health risks related to the sound abatement foam component in certain sleep and respiratory care devices

Media contact

Steve Klink

Mario Fante

Get the latest Philips news in your inbox

This page is intended to provide the latest information on the Philips
Respironics voluntary recall notification, as well as an overview of
previous updates, for media.

Healthcare providers, patients, and other stakeholders should visit:
www.philips.com/src-update